Literature DB >> 25850793

Therapy: Are long-acting intramuscular testosterone injections safe?

Michael Zitzmann1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25850793     DOI： 10.1038/nrurol.2015.73

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  10 in total

1.  Oil embolism in lymphangiography. Incidence, manifestations, and mechanism.

Authors:  K M BRON; S BAUM; H L ABRAMS
Journal:  Radiology       Date:  1963-02       Impact factor: 11.105

2.  Complications of injectable testosterone undecanoate in routine clinical practice.

Authors:  T Middleton; L Turner; C Fennell; S Savkovic; V Jayadev; A J Conway; D J Handelsman
Journal:  Eur J Endocrinol       Date:  2015-01-30       Impact factor: 6.664

3.  IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men.

Authors:  Michael Zitzmann; Andreas Mattern; Jens Hanisch; Louis Gooren; Hugh Jones; Mario Maggi
Journal:  J Sex Med       Date:  2012-07-19       Impact factor: 3.802

4.  Microscopic evidence of lymphogenic absorption of oil in humans receiving neuroleptic oily depot preparations intramuscularly.

Authors:  O Svendsen; S J Dencker; R Fog; A O Gravem; P Kristjansen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1980-08

5.  Studies on the fate of vegetable oit after intramuscular injection into experimental animals.

Authors:  O Svendsen; T Aaes-Jørgensen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1979-11

6.  Tolerability of intramuscular injections of testosterone ester in oil vehicle.

Authors:  M A Mackey; A J Conway; D J Handelsman
Journal:  Hum Reprod       Date:  1995-04       Impact factor: 6.918

7.  Effects of various modes of androgen substitution therapy on erythropoiesis.

Authors:  F Jockenhövel; E Vogel; W Reinhardt; D Reinwein
Journal:  Eur J Med Res       Date:  1997-07-28       Impact factor: 2.175

8.  Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point.

Authors:  Eric Bachman; Thomas G Travison; Shehzad Basaria; Maithili N Davda; Wen Guo; Michelle Li; John Connor Westfall; Harold Bae; Victor Gordeuk; Shalender Bhasin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-10-24       Impact factor: 6.053

9.  Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men.

Authors:  A S Dobs; A W Meikle; S Arver; S W Sanders; K E Caramelli; N A Mazer
Journal:  J Clin Endocrinol Metab       Date:  1999-10       Impact factor: 5.958

10.  Effects of graded doses of testosterone on erythropoiesis in healthy young and older men.

Authors:  Andrea D Coviello; Beth Kaplan; Kishore M Lakshman; Tai Chen; Atam B Singh; Shalender Bhasin
Journal:  J Clin Endocrinol Metab       Date:  2007-12-26       Impact factor: 5.958
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.